Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

1.

Indol-3-yl-tetramethylcyclopropyl ketones: effects of indole ring substitution on CB2 cannabinoid receptor activity.

Frost JM, Dart MJ, Tietje KR, Garrison TR, Grayson GK, Daza AV, El-Kouhen OF, Miller LN, Li L, Yao BB, Hsieh GC, Pai M, Zhu CZ, Chandran P, Meyer MD.

J Med Chem. 2008 Mar 27;51(6):1904-12. doi: 10.1021/jm7011613. Epub 2008 Feb 27.

PMID:
18311894
[PubMed - indexed for MEDLINE]
2.

Indoles and related compounds as cannabinoid ligands.

Manera C, Tuccinardi T, Martinelli A.

Mini Rev Med Chem. 2008 Apr;8(4):370-87. Review.

PMID:
18473928
[PubMed - indexed for MEDLINE]
3.

CB2 receptor ligands.

Huffman JW.

Mini Rev Med Chem. 2005 Jul;5(7):641-9. Review.

PMID:
16026310
[PubMed - indexed for MEDLINE]
4.

Recent developments in the medicinal chemistry of cannabimimetic indoles, pyrroles and indenes.

Huffman JW, Padgett LW.

Curr Med Chem. 2005;12(12):1395-411. Review.

PMID:
15974991
[PubMed - indexed for MEDLINE]
5.

Recent advances in the development of selective ligands for the cannabinoid CB(2) receptor.

Marriott KS, Huffman JW.

Curr Top Med Chem. 2008;8(3):187-204. Review.

PMID:
18289088
[PubMed - indexed for MEDLINE]
6.

Simultaneous optimization of potency, selectivity and physicochemical properties for cannabinoid CB(2) ligands.

Worm K, Dolle RE.

Curr Pharm Des. 2009;15(29):3345-66. Review.

PMID:
19860684
[PubMed - indexed for MEDLINE]
7.

Cannabinoid receptors and their ligands: ligand-ligand and ligand-receptor modeling approaches.

Reggio PH.

Handb Exp Pharmacol. 2005;(168):247-81. Review.

PMID:
16596777
[PubMed - indexed for MEDLINE]
8.

Structural requirements for cannabinoid receptor probes.

Thakur GA, Nikas SP, Li C, Makriyannis A.

Handb Exp Pharmacol. 2005;(168):209-46. Review.

PMID:
16596776
[PubMed - indexed for MEDLINE]
9.

Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists.

Ashton JC, Wright JL, McPartland JM, Tyndall JD.

Curr Med Chem. 2008;15(14):1428-43. Review.

PMID:
18537620
[PubMed - indexed for MEDLINE]
10.

Targeting cannabinoid agonists for inflammatory and neuropathic pain.

Cheng Y, Hitchcock SA.

Expert Opin Investig Drugs. 2007 Jul;16(7):951-65. Review.

PMID:
17594182
[PubMed - indexed for MEDLINE]
11.

Targeting CB2 receptors and the endocannabinoid system for the treatment of pain.

Anand P, Whiteside G, Fowler CJ, Hohmann AG.

Brain Res Rev. 2009 Apr;60(1):255-66. doi: 10.1016/j.brainresrev.2008.12.003. Epub 2008 Dec 25. Review.

PMID:
19150370
[PubMed - indexed for MEDLINE]
12.

Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis.

Janero DR, Makriyannis A.

Expert Opin Emerg Drugs. 2009 Mar;14(1):43-65. doi: 10.1517/14728210902736568 . Review.

PMID:
19249987
[PubMed - indexed for MEDLINE]
13.

Targeting the cannabinoid CB2 receptor: modelling and structural determinants of CB2 selective ligands.

Poso A, Huffman JW.

Br J Pharmacol. 2008 Jan;153(2):335-46. Epub 2007 Nov 5. Review.

PMID:
17982473
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Cannabimimetic indoles, pyrroles and indenes.

Huffman JW.

Curr Med Chem. 1999 Aug;6(8):705-20. Review.

PMID:
10469887
[PubMed - indexed for MEDLINE]
15.

Recent advances in the development of selective CB(2) agonists as promising anti-inflammatory agents.

Leleu-Chavain N, Body-Malapel M, Spencer J, Chavatte P, Desreumaux P, Millet R.

Curr Med Chem. 2012;19(21):3457-74. Review.

PMID:
22709008
[PubMed - indexed for MEDLINE]
16.

Cannabinoid type 2 receptor as a target for chronic - pain.

Beltramo M.

Mini Rev Med Chem. 2009 Jan;9(1):11-25. Review.

PMID:
19149657
[PubMed - indexed for MEDLINE]
17.

Allosterism and cannabinoid CB(1) receptors: the shape of things to come.

Ross RA.

Trends Pharmacol Sci. 2007 Nov;28(11):567-72. Review.

PMID:
18029031
[PubMed - indexed for MEDLINE]
18.

[Recent advances in the study of pharmacological activities and solid-phase synthesis of indoles and their analogues].

Yang TM, Liu G.

Yao Xue Xue Bao. 2006 Aug;41(8):694-701. Review. Chinese. No abstract available.

PMID:
17039771
[PubMed - indexed for MEDLINE]
19.

Tricyclic quinoxalinediones, aza-kynurenic acids, and indole-2-carboxylic acids as in vivo active NMDA-glycine antagonists.

Nagata R, Katayama S, Ohtani K, Tanaka H, Shimago K.

Curr Top Med Chem. 2006;6(7):733-45. Review.

PMID:
16719813
[PubMed - indexed for MEDLINE]
20.

Polyfunctional indole-3-carbinol derivatives: 1-(indol-3-yl)glycerols and related compounds, beta-hydroxytryptamines and ascorbigens. Chemistry and biological properties.

Preobrazhenskaya MN, Korolev AM, Isaeva NN, Lazhko EI, Lomidze LA.

Farmaco. 1995 Jun;50(6):369-77. Review.

PMID:
7669176
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk